Restorative potential of (-)-epicatechin in a rat model of Gulf War illness muscle atrophy and fatigue.
Restorative potential of (-)-epicatechin in a rat model of Gulf War illness muscle atrophy and fatigue.
复制标题
DOI:
10.1038/s41598-021-01093-w
复制
发表时间:
2021-11-08
影响因子:
4.6
通讯作者:
Villarreal F
中科院分区:
文献类型:
--
作者:
Ramirez-Sanchez I;Navarrete-Yañez V;Garate-Carrillo A;Lara-Hernandez M;Espinosa-Raya J;Moreno-Ulloa A;Gomez-Diaz B;Cedeño-Garcidueñas AL;Ceballos G;Villarreal F
We examined in a rat model of Gulf War illness (GWI), the potential of (−)-epicatechin (Epi) to reverse skeletal muscle (SkM) atrophy and dysfunction, decrease mediators of inflammation and normalize metabolic perturbations. Male Wistar rats (n = 15) were provided orally with pyridostigmine bromide (PB) 1.3 mg/kg/day, permethrin (PM) 0.13 mg/kg/day (skin), DEET 40 mg/kg/day (skin) and were physically restrained for 5 min/day for 3 weeks. A one-week period ensued to fully develop the GWI-like profile followed by 2 weeks of either Epi treatment at 1 mg/kg/day by gavage (n = 8) or water (n = 7) for controls. A normal, control group (n = 15) was given vehicle and not restrained. At 6 weeks, animals were subjected to treadmill and limb strength testing followed by euthanasia. SkM and blood sampling was used for histological, biochemical and plasma pro-inflammatory cytokine and metabolomics assessments. GWI animals developed an intoxication profile characterized SkM atrophy and loss of function accompanied by increases in modulators of muscle atrophy, degradation markers and plasma pro-inflammatory cytokine levels. Treatment of GWI animals with Epi yielded either a significant partial or full normalization of the above stated indicators relative to normal controls. Plasma metabolomics revealed that metabolites linked to inflammation and SkM waste pathways were dysregulated in the GWI group whereas Epi, attenuated such changes. In conclusion, in a rat model of GWI, Epi partially reverses detrimental changes in SkM structure including modulators of atrophy, inflammation and select plasma metabolites yielding improved function.
登录
查看更多内容
影响因子:
4.6
作者:
Joshi U;Evans JE;Joseph R;Emmerich T;Saltiel N;Lungmus C;Oberlin S;Langlois H;Ojo J;Mouzon B;Paris D;Mullan M;Jin C;Klimas N;Sullivan K;Crawford F;Abdullah L
通讯作者:
Abdullah L
影响因子:
4.3
作者:
da Silva RR;Wang M;Nothias LF;van der Hooft JJJ;Caraballo-Rodríguez AM;Fox E;Balunas MJ;Klassen JL;Lopes NP;Dorrestein PC
通讯作者:
Dorrestein PC
DOI:
10.1136/bmj.d4488
发表时间:
2011-08-26
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Buitrago-Lopez A;Sanderson J;Johnson L;Warnakula S;Wood A;Di Angelantonio E;Franco OH
通讯作者:
Franco OH
影响因子:
4.3
作者:
ADAMS, JG;DHAR, A;SILVER, D
通讯作者:
SILVER, D
影响因子:
8.6
作者:
Djoumbou Feunang Y;Eisner R;Knox C;Chepelev L;Hastings J;Owen G;Fahy E;Steinbeck C;Subramanian S;Bolton E;Greiner R;Wishart DS
通讯作者:
Wishart DS